Search - tctmd.com

Displaying 1 - 20 of 119

Sort: Relevancy | Date

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

Presenter: Terumitsu Hasebe

October 27, 2025

Presentation TCT 2025

TCT 925: Peripheral Endovascular Intervention with Atherectomy in Below-The-Knee Arteries: A Report from The XLPAD Registry

Presenter: Minseob Jeong

October 26, 2025

Presentation TCT 2024

TCT 709: The Novel Hybrid Nano-coating Ni-Ti stent for below-the-knee atherosclerotic disease: The Newest “Leave the Right Thing Behind”Concept

Presenter: Terumitsu Hasebe

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

Presenter: Minseob Jeong

October 27, 2024

Presentation TCT 2024

TCT 396: Outcomes of Below the Knee Chronic Total Occlusions Interventions: Insights From the XLPAD Registry

Presenter: Deepakraj Gajanana

October 27, 2024

Presentation TCT 2024

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

Presenter: Minseob Jeong

October 27, 2024

Presentation TCT 2024

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Presenter: Emi Kearon

October 27, 2024

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

Presenter: Terumitsu Hasebe

October 25, 2023

Presentation TCT 2023

TCT 548: Pathology of Balloon Angioplasty for Below-the-Knee Arteries in Patients With Chronic Limb-Threatening Ischemia

Presenter: Manabu Shiozaki

October 25, 2023

Presentation TCT 2023

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

Presenter: Eric Secemsky

October 25, 2023

Presentation TCT 2023

TCT 566: Tyrosine Polycarbonate Bioresorbable Scaffold for Below-the Knee Application: Pilot Study of Biocompatibility in Small Caliber Porcine Peripheral Arteries

Presenter: Mateusz Kachel

October 25, 2023

Presentation TCT 2023

TCT 188: Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee Arteries: 30-Day Results of the Auryon BTK

Presenter: Nicolas Shammas

October 25, 2023

Presentation TCT 2023

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

Presenter: Daniel Snyder

October 24, 2023

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

Presentation TCT 2020

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

Presenter: Ehrin J. Armstrong

October 18, 2020

Presentation TCT 2020

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

Presenter: Ehrin Armstrong

October 18, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

Advertisement

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

TCT 925: Peripheral Endovascular Intervention with Atherectomy in Below-The-Knee Arteries: A Report from The XLPAD Registry

TCT 709: The Novel Hybrid Nano-coating Ni-Ti stent for below-the-knee atherosclerotic disease: The Newest “Leave the Right Thing Behind”Concept

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

TCT 396: Outcomes of Below the Knee Chronic Total Occlusions Interventions: Insights From the XLPAD Registry

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

TCT 649: Impact of a Novel Hybrid Nano-coated Nitinol Drug-eluting Stent (Hybrid-DES) on Below-the-knee Atherosclerotic Disease: 2023 Update

TCT 548: Pathology of Balloon Angioplasty for Below-the-Knee Arteries in Patients With Chronic Limb-Threatening Ischemia

Angiographic and Clinical Outcomes of the Thin-Strut MAGNITUDE Bioresorbable Scaffold in Patients with Below-the-Knee Arterial Disease: Early Results from the RESOLV I Trial

TCT 566: Tyrosine Polycarbonate Bioresorbable Scaffold for Below-the Knee Application: Pilot Study of Biocompatibility in Small Caliber Porcine Peripheral Arteries

TCT 188: Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee Arteries: 30-Day Results of the Auryon BTK

TCT 627: Binary Restenosis Rates Following Percutaneous Transluminal Angioplasty for Below-the-Knee Chronic Limb-Threatening Ischemia: A Meta-Analysis of Randomized Controlled Trial Data

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content